BRTX
Price
$1.52
Change
+$0.01 (+0.66%)
Updated
Aug 26 closing price
Capitalization
12.16M
83 days until earnings call
CERO
Price
$7.75
Change
-$0.11 (-1.40%)
Updated
Aug 26 closing price
Capitalization
9.47M
Interact to see
Advertisement

BRTX vs CERO

Header iconBRTX vs CERO Comparison
Open Charts BRTX vs CEROBanner chart's image
BioRestorative Therapies
Price$1.52
Change+$0.01 (+0.66%)
Volume$6.47K
Capitalization12.16M
CERO Therapeutics Holdings
Price$7.75
Change-$0.11 (-1.40%)
Volume$23.3K
Capitalization9.47M
BRTX vs CERO Comparison Chart in %
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. CERO commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a StrongBuy and CERO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (BRTX: $1.52 vs. CERO: $7.75)
Brand notoriety: BRTX and CERO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 10% vs. CERO: 16%
Market capitalization -- BRTX: $12.16M vs. CERO: $9.47M
BRTX [@Biotechnology] is valued at $12.16M. CERO’s [@Biotechnology] market capitalization is $9.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 1 FA rating(s) are green whileCERO’s FA Score has 1 green FA rating(s).

  • BRTX’s FA Score: 1 green, 4 red.
  • CERO’s FA Score: 1 green, 4 red.
According to our system of comparison, CERO is a better buy in the long-term than BRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 5 TA indicator(s) are bullish while CERO’s TA Score has 2 bullish TA indicator(s).

  • BRTX’s TA Score: 5 bullish, 4 bearish.
  • CERO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BRTX is a better buy in the short-term than CERO.

Price Growth

BRTX (@Biotechnology) experienced а +1.28% price change this week, while CERO (@Biotechnology) price change was -10.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was +23.07%, and the average quarterly price growth was +32.06%.

Reported Earning Dates

BRTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRTX($12.2M) has a higher market cap than CERO($9.47M). BRTX YTD gains are higher at: 6.587 vs. CERO (-93.542). CERO has higher annual earnings (EBITDA): -8.49M vs. BRTX (-12.89M). BRTX has more cash in the bank: 7.38M vs. CERO (5.2M). BRTX has less debt than CERO: BRTX (42.4K) vs CERO (1.37M). BRTX has higher revenues than CERO: BRTX (605K) vs CERO (0).
BRTXCEROBRTX / CERO
Capitalization12.2M9.47M129%
EBITDA-12.89M-8.49M152%
Gain YTD6.587-93.542-7%
P/E RatioN/AN/A-
Revenue605K0-
Total Cash7.38M5.2M142%
Total Debt42.4K1.37M3%
FUNDAMENTALS RATINGS
BRTX: Fundamental Ratings
BRTX
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRTXCERO
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
14%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
42%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
36%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
26%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 20 days ago
55%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
22%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAVL0.970.13
+15.80%
Kaival Brands Innovations Group
ODV2.870.26
+9.96%
Osisko Development Corp
ON50.990.04
+0.08%
ON Semiconductor Corp
CPK124.00-0.42
-0.34%
Chesapeake Utilities
NNBR2.42-0.02
-0.82%
NN

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
+0.94%
TCRT - BRTX
33%
Loosely correlated
-5.08%
CERO - BRTX
29%
Poorly correlated
-1.40%
GRCE - BRTX
28%
Poorly correlated
-1.08%
ORIC - BRTX
28%
Poorly correlated
+2.39%
KYMR - BRTX
28%
Poorly correlated
+4.90%
More

CERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERO has been loosely correlated with UNCY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CERO jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
-1.40%
UNCY - CERO
37%
Loosely correlated
-0.93%
UTHR - CERO
34%
Loosely correlated
+1.26%
ACXP - CERO
33%
Loosely correlated
-3.91%
BRTX - CERO
30%
Poorly correlated
+0.94%
LQDA - CERO
26%
Poorly correlated
+5.64%
More